CVE-2023-30990

CVE-2023-30990 is a high-severity vulnerability in Ibm I with a CVSS 3.x base score of 8.6. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-94.

Key facts

Description

IBM i 7.2, 7.3, 7.4, and 7.5 could allow a remote attacker to execute CL commands as QUSER, caused by an exploitation of DDM architecture. IBM X-Force ID: 254036.

Frequently asked questions

What is CVE-2023-30990?
IBM i 7.2, 7.3, 7.4, and 7.5 could allow a remote attacker to execute CL commands as QUSER, caused by an exploitation of DDM architecture. IBM X-Force ID: 254036.
How severe is CVE-2023-30990?
CVE-2023-30990 has a CVSS 3.x base score of 8.6, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability high.
Is CVE-2023-30990 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (59th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-30990?
CVE-2023-30990 primarily affects Ibm I. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2023-30990?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-30990 published?
CVE-2023-30990 was published on 2023-07-04 and last updated on 2026-06-17.

References

Affected products (4)

More vulnerabilities in Ibm I

All CVEs affecting Ibm I →

Other CWE-94 (Code Injection) vulnerabilities

Browse all CWE-94 (Code Injection) vulnerabilities →